GlassScriptPhysician profile
Winsome Parchment
NPI 1972598829
$1,751.32
in general payments reported to CMS, 2019-2025
27 companies · $498 in 2025
The $498 reported for 2025 was more than what 79% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $442 · 2020: $110 · 2021: $12.92 · 2022: $174 · 2023: $338 · 2024: $177 · 2025: $498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,013.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,012.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $320.97 | 2019-2025 | |
| Astellas Pharma US INC | $167.81 | 2023-2025 | Veozah, Myrbetriq |
| Amag Pharmaceuticals, INC. | $140.94 | 2019 | |
| Lupin INC. | $123.69 | 2019-2020 | |
| Organon LLC | $106.26 | 2022-2025 | Nexplanon |
| Abbvie INC. | $87.61 | 2019-2023 | |
| Evofem Biosciences, INC. | $80.35 | 2023-2025 | Phexxi, Solosec, Phexx |
| Dysis Medical, INC. | $79.31 | 2020-2022 | |
| Vertical Pharmaceuticals, LLC | $78.95 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $71.37 | 2024-2025 | |
| Mayne Pharma Commercial LLC | $66.35 | 2023-2025 | |
| Millicent US INC | $48.65 | 2024-2025 | Intrarosa, Femlyv |
| Agile Therapeutics, INC. | $48.28 | 2022-2024 | Twirla |
| Exact Sciences Corporation | $48.20 | 2025 | The Cologuard Plus Collection Kit |
| Pfizer INC. | $37.20 | 2019-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $31.49 | 2022 | |
| Smith+Nephew, INC. | $30.37 | 2025 | Pico 14 |
| Allergan, INC. | $28.69 | 2019 | |
| Medtronic, INC. | $23.91 | 2023 | Endo Stitch |
| Gynesonics, INC. | $22.41 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Exeltis, USA INC. | $20.00 | 2024 | Slynd |
| Mylan Pharmaceuticals INC. | $16.19 | 2022 | |
| Myovant Sciences INC. | $16.07 | 2022 | |
| Merck Sharp & Dohme LLC | $14.96 | 2019 | |
| Therapeuticsmd, INC. | $14.21 | 2019 | |
| Coopersurgical, INC. | $14.16 | 2023 | Paragard T 380a |
| Avion Pharmaceuticals | $12.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Winsome Parchment listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.